Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 214

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Cardiac remodeling and failure

Fedak, Paul W.M., Verma, Subodh, Weisel, Richard D., Li, Ren-Ke·2005·Cardiovascular Pathology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.carpath.2004.12.002

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Research works printed but not linked: 114

  1. Lloyd-Jones, 2002, Lifetime risk for developing congestive heart failure: the Framingham Heart Study, Circulation, 106, 3068, 10.1161/01.CIR.0000039105.49749.6F · DOI · Paper page
  2. Zeltsman, 2002, Surgical management of heart failure: an overview, Annu Rev Med, 53, 383, 10.1146/annurev.med.53.082901.104101 · DOI
  3. Braunwald, 2000, Congestive heart failure: fifty years of progress, Circulation, 102, IV14
  4. Mann, 1999, Mechanisms and models in heart failure: a combinatorial approach, Circulation, 100, 999, 10.1161/01.CIR.100.9.999 · DOI · Paper page
  5. Cohn, 1997, Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research, Circulation, 95, 766, 10.1161/01.CIR.95.4.766 · DOI · Paper page
  6. Zile, 2002, New concepts in diastolic dysfunction and diastolic heart failure: Part II. Causal mechanisms and treatment, Circulation, 105, 1503, 10.1161/hc1202.105290 · DOI · Paper page
  7. Zile, 2002, New concepts in diastolic dysfunction and diastolic heart failure: Part I. Diagnosis, prognosis, and measurements of diastolic function, Circulation, 105, 1387, 10.1161/hc1102.105289 · DOI · Paper page
  8. Hoshijima, 2002, Mixed signals in heart failure: cancer rules, J Clin Invest, 109, 849, 10.1172/JCI0215380 · DOI
  9. Swynghedauw, 1999, Molecular mechanisms of myocardial remodeling, Physiol Rev, 79, 215, 10.1152/physrev.1999.79.1.215 · DOI · Paper page
  10. Cohn, 2000, Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling, J Am Coll Cardiol, 35, 569, 10.1016/S0735-1097(99)00630-0 · DOI · Paper page
  11. Udelson, 2002, Relation between left ventricular remodeling and clinical outcomes in heart failure patients with left ventricular systolic dysfunction, J Card Fail, 8, S465, 10.1054/jcaf.2002.129289 · DOI
  12. Spotnitz, 2000, Macro design, structure, and mechanics of the left ventricle, J Thorac Cardiovasc Surg, 119, 1053, 10.1016/S0022-5223(00)70106-1 · DOI
  13. Carabello, 2002, Concentric versus eccentric remodeling, J Card Fail, 8, S258, 10.1054/jcaf.2002.129250 · DOI
  14. Linzbach, 1960, Heart failure from the point of view of quantitative anatomy, Am J Cardiol, 5, 370, 10.1016/0002-9149(60)90084-9 · DOI · Paper page
  15. Plante, 2003, Left ventricular response to sustained volume overload from chronic aortic valve regurgitation in rats, J Card Fail, 9, 128, 10.1054/jcaf.2003.17 · doi:10.1054/jcaf.2003.17
  16. Brower, 2001, Contribution of ventricular remodeling to pathogenesis of heart failure in rats, Am J Physiol Heart Circ Physiol, 280, H674, 10.1152/ajpheart.2001.280.2.H674 · DOI
  17. Pfeffer, 1987, Ventricular enlargement and reduced survival after myocardial infarction, Circulation, 75, IV93
  18. St John, 1997, Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial, Circulation, 96, 3294, 10.1161/01.CIR.96.10.3294 · DOI · Paper page
  19. de Kam, 2002, Prediction of 6 months left ventricular dilatation after myocardial infarction in relation to cardiac morbidity and mortality. Application of a new dilatation model to GISSI-3 data, Eur Heart J, 23, 536, 10.1053/euhj.2001.2820 · doi:10.1053/euhj.2001.2820
  20. Gaudron, 1993, Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors, Circulation, 87, 755, 10.1161/01.CIR.87.3.755 · DOI · Paper page
  21. Dickstein, 1997, Heart reduction surgery: an analysis of the impact on cardiac function, J Thorac Cardiovasc Surg, 113, 1032, 10.1016/S0022-5223(97)70288-5 · doi:10.1016/s0022-5223(97)70288-5
  22. Bolognese, 2002, Left ventricular remodeling after primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implications, Circulation, 106, 2351, 10.1161/01.CIR.0000036014.90197.FA · DOI · Paper page
  23. Houser, 2003, Is depressed myocyte contractility centrally involved in heart failure?, Circ Res, 92, 350, 10.1161/01.RES.0000060027.40275.A6 · DOI · Paper page
  24. Davies, 1995, Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure, Circulation, 92, 2540, 10.1161/01.CIR.92.9.2540 · DOI · Paper page
  25. Harding, 1995, Abnormalities of the myocytes in ischaemic cardiomyopathy, Eur Heart J, 16, 74, 10.1093/eurheartj/16.suppl_I.74 · doi:10.1093/eurheartj/16.suppl_i.74
  26. Anand, 1997, Isolated myocyte contractile function is normal in postinfarct remodeled rat heart with systolic dysfunction, Circulation, 96, 3974, 10.1161/01.CIR.96.11.3974 · DOI
  27. Baicu, 2003, Changes in extracellular collagen matrix alter myocardial systolic performance, Am J Physiol Heart Circ Physiol, 284, H122, 10.1152/ajpheart.00233.2002 · DOI
  28. Sugden, 1999, Signaling in myocardial hypertrophy: life after calcineurin?, Circ Res, 84, 633, 10.1161/01.RES.84.6.633 · DOI · Paper page
  29. Weber, 1989, Myocardial collagen remodeling in pressure overload hypertrophy. A case for interstitial heart disease, Am J Hypertens, 2, 931, 10.1093/ajh/2.12.931 · DOI
  30. Litwin, 1991, Induction of myocardial hypertrophy after coronary ligation in rats decreases ventricular dilatation and improves systolic function, Circulation, 84, 1819, 10.1161/01.CIR.84.4.1819 · DOI
  31. Liao, 2002, Shedding growth factors in cardiac hypertrophy, Nat Med, 8, 20, 10.1038/nm0102-20 · doi:10.1038/nm0102-20
  32. Asakura, 2002, Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy, Nat Med, 8, 35, 10.1038/nm0102-35 · DOI · Paper page
  33. Terracio, 1991, Expression of collagen binding integrins during cardiac development and hypertrophy, Circ Res, 68, 734, 10.1161/01.RES.68.3.734 · DOI · Paper page
  34. Ross, 2001, Integrins and the myocardium, Circ Res, 88, 1112, 10.1161/hh1101.091862 · DOI · Paper page
  35. Gerdes, 1995, Structural remodeling and mechanical dysfunction of cardiac myocytes in heart failure, J Mol Cell Cardiol, 27, 849, 10.1016/0022-2828(95)90000-4 · DOI · Paper page
  36. Gerdes, 2002, Cardiac myocyte remodeling in hypertrophy and progression to failure, J Card Fail, 8, S264, 10.1054/jcaf.2002.129280 · DOI
  37. Spinale, 1993, Structural basis for changes in left ventricular function and geometry because of chronic mitral regurgitation and after correction of volume overload, J Thorac Cardiovasc Surg, 106, 1147, 10.1016/S0022-5223(19)33992-3 · DOI
  38. Tamura, 1998, Correlation of myocyte lengthening to chamber dilation in the spontaneously hypertensive heart failure (SHHF) rat, J Mol Cell Cardiol, 30, 2175, 10.1006/jmcc.1998.0775 · DOI
  39. Onodera, 1998, Maladaptive remodeling of cardiac myocyte shape begins long before failure in hypertension, Hypertension, 32, 753, 10.1161/01.HYP.32.4.753 · DOI
  40. Spotnitz, 1974, Cellular basis for volume related wall thickness changes in the rat left ventricle, J Mol Cell Cardiol, 6, 317, 10.1016/0022-2828(74)90074-1 · DOI
  41. Kang, 2000, Apoptosis and heart failure: a critical review of the literature, Circ Res, 86, 1107, 10.1161/01.RES.86.11.1107 · DOI · Paper page
  42. Li, 1997, Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat, Am J Physiol, 272, H2313
  43. Mani, 2003, Myocyte apoptosis: programming ventricular remodeling, J Am Coll Cardiol, 41, 761, 10.1016/S0735-1097(02)02958-3 · DOI
  44. Condorelli, 1999, Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes bax and bcl-2 during left ventricular adaptations to chronic pressure overload in the rat, Circulation, 99, 3071, 10.1161/01.CIR.99.23.3071 · DOI · Paper page
  45. Yue, 1998, Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol, Circ Res, 82, 166, 10.1161/01.RES.82.2.166 · DOI · Paper page
  46. Schulze-Osthoff, 1998, Apoptosis signaling by death receptors, Eur J Biochem, 254, 439, 10.1046/j.1432-1327.1998.2540439.x · DOI · Paper page
  47. Abbate, 2003, Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure, J Am Coll Cardiol, 41, 753, 10.1016/S0735-1097(02)02959-5 · DOI · Paper page
  48. Schaper, 1999, The role of apoptosis in dilated cardiomyopathy, Herz, 24, 219, 10.1007/BF03044964 · DOI
  49. Saraste, 1999, Cardiomyocyte apoptosis and progression of heart failure to transplantation, Eur J Clin Invest, 29, 380, 10.1046/j.1365-2362.1999.00481.x · DOI · Paper page
  50. Chatterjee, 1999, Viral gene transfer of the antiapoptotic factor Bcl-2 protects against chronic postischemic heart failure, Circulation, 106, 1212
  51. Ren, 1999, Insulin-like growth factor I as a cardiac hormone: physiological and pathophysiological implications in heart disease, J Mol Cell Cardiol, 31, 2049, 10.1006/jmcc.1999.1036 · DOI · Paper page
  52. Li, 1997, Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy, J Clin Invest, 100, 1991, 10.1172/JCI119730 · DOI · Paper page
  53. Lee, 1999, Insulin-like growth factor I improves cardiovascular function and suppresses apoptosis of cardiomyocytes in dilated cardiomyopathy, Endocrinology, 140, 4831, 10.1210/en.140.10.4831 · doi:10.1210/en.140.10.4831
  54. Ding, 2000, Left ventricular hypertrophy in ascending aortic stenosis mice: anoikis and the progression to early failure, Circulation, 101, 2854, 10.1161/01.CIR.101.24.2854 · DOI
  55. Nadal-Ginard, 2003, Myocyte death, growth, and regeneration in cardiac hypertrophy and failure, Circ Res, 92, 139, 10.1161/01.RES.0000053618.86362.DF · DOI · Paper page
  56. Nadal-Ginard, 2003, A matter of life and death: cardiac myocyte apoptosis and regeneration, J Clin Invest, 111, 1457, 10.1172/JCI200318611 · DOI
  57. Anversa, 2002, Myocyte renewal and ventricular remodeling, Nature, 415, 240, 10.1038/415240a · DOI · Paper page
  58. Soonpaa, 1998, Survey of studies examining mammalian cardiomyocyte DNA synthesis, Circ Res, 83, 15, 10.1161/01.RES.83.1.15 · DOI · Paper page
  59. Anversa, 2002, Cardiac chimerism: methods matter, Circulation, 106, e129, 10.1161/01.CIR.0000035926.40150.D0 · doi:10.1161/01.cir.0000035926.40150.d0
  60. Anversa, 1998, Ventricular myocytes are not terminally differentiated in the adult mammalian heart, Circ Res, 83, 1, 10.1161/01.RES.83.1.1 · DOI · Paper page
  61. Beltrami, 2001, Evidence that human cardiac myocytes divide after myocardial infarction, N Engl J Med, 344, 1750, 10.1056/NEJM200106073442303 · DOI · Paper page
  62. Kajstura, 1998, Myocyte proliferation in end-stage cardiac failure in humans, Proc Natl Acad Sci U S A, 95, 8801, 10.1073/pnas.95.15.8801 · DOI · Paper page
  63. Orlic, 2002, Stem cells for myocardial regeneration, Circ Res, 91, 1092, 10.1161/01.RES.0000046045.00846.B0 · DOI · Paper page
  64. Orlic, 2001, Transplanted adult bone marrow cells repair myocardial infarcts in mice, Ann N Y Acad Sci, 938, 221, 10.1111/j.1749-6632.2001.tb03592.x · DOI · Paper page
  65. Orlic, 2001, Bone marrow cells regenerate infarcted myocardium, Nature, 410, 701, 10.1038/35070587 · DOI · Paper page
  66. Orlic, 2001, Mobilized bone marrow cells repair the infarcted heart, improving function and survival, Proc Natl Acad Sci U S A, 98, 10344, 10.1073/pnas.181177898 · DOI · Paper page
  67. Quaini, 2002, Chimerism of the transplanted heart, N Engl J Med, 346, 5, 10.1056/NEJMoa012081 · DOI · Paper page
  68. Laflamme, 2002, Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts, Circ Res, 90, 634, 10.1161/01.RES.0000014822.62629.EB · DOI · Paper page
  69. Deb, 2003, Bone marrow-derived cardiomyocytes are present in adult human heart: a study of gender-mismatched bone marrow transplantation patients, Circulation, 107, 1247, 10.1161/01.CIR.0000061910.39145.F0 · DOI · Paper page
  70. Nadal-Ginard, 2002, Chimera or not chimera?, Circ Res, 90, E72, 10.1161/01.RES.0000019363.77779.1D · doi:10.1161/01.res.0000019363.77779.1d
  71. Patten, 2000, Ventricular remodeling and the renin angiotensin aldosterone system, Congest Heart Fail, 6, 187, 10.1111/j.1527-5299.2000.80159.x · DOI
  72. Sadoshima, 1993, Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro, Cell, 75, 977, 10.1016/0092-8674(93)90541-W · DOI · Paper page
  73. Sadoshima, 1993, Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype, Circ Res, 73, 413, 10.1161/01.RES.73.3.413 · DOI · Paper page
  74. Walther, 2002, Left ventricular reverse remodeling after surgical therapy for aortic stenosis: correlation to renin–angiotensin system gene expression, Circulation, 106, 123
  75. Liu, 2001, The 2001 Canadian Cardiovascular Society consensus guideline update for the management and prevention of heart failure, Can J Cardiol, 17, 5E
  76. Labinjoh, 2001, Potentiation of bradykinin-induced tissue plasminogen activator release by angiotensin-converting enzyme inhibition, J Am Coll Cardiol, 38, 1402, 10.1016/S0735-1097(01)01562-5 · DOI
  77. Witherow, 2001, Bradykinin contributes to the vasodilator effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure, Circulation, 104, 2177, 10.1161/hc4301.098252 · DOI
  78. Jong, 2002, Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trials, J Am Coll Cardiol, 39, 463, 10.1016/S0735-1097(01)01775-2 · DOI · Paper page
  79. Silvestre, 1998, Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation, J Biol Chem, 273, 4883, 10.1074/jbc.273.9.4883 · DOI · Paper page
  80. Weber, 2001, Aldosterone in congestive heart failure, N Engl J Med, 345, 1689, 10.1056/NEJMra000050 · DOI · Paper page
  81. Weber, 1997, Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation, Circulation, 96, 4065, 10.1161/01.CIR.96.11.4065 · DOI · Paper page
  82. Swedberg, 1990, Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group, Circulation, 82, 1730, 10.1161/01.CIR.82.5.1730 · DOI · Paper page
  83. Soberman, 2002, Aldosterone antagonists in congestive heart failure, Curr Opin Investig Drugs, 3, 1024
  84. Zannad, 2000, Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators, Circulation, 102, 2700, 10.1161/01.CIR.102.22.2700 · DOI · Paper page
  85. Swedberg, 1984, Comparison of myocardial catecholamine balance in chronic congestive heart failure and in angina pectoris without failure, Am J Cardiol, 54, 783, 10.1016/S0002-9149(84)80208-8 · DOI · Paper page
  86. Port, 2001, Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure, J Mol Cell Cardiol, 33, 887, 10.1006/jmcc.2001.1358 · DOI · Paper page
  87. Mann, 1992, Adrenergic effects on the biology of the adult mammalian cardiocyte, Circulation, 85, 790, 10.1161/01.CIR.85.2.790 · DOI · Paper page
  88. Engelhardt, 1999, Progressive hypertrophy and heart failure in beta 1-adrenergic receptor transgenic mice, Proc Natl Acad Sci U S A, 96, 7059, 10.1073/pnas.96.12.7059 · DOI · Paper page
  89. Francis, 1990, Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD), Circulation, 82, 1724, 10.1161/01.CIR.82.5.1724 · DOI · Paper page
  90. Bristow, 2000, Mechanistic and clinical rationales for using beta-blockers in heart failure, J Card Fail, 6, 8
  91. Eichhorn, 1996, Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure, Circulation, 94, 2285, 10.1161/01.CIR.94.9.2285 · DOI · Paper page
  92. Hall, 1995, Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade, J Am Coll Cardiol, 25, 1154, 10.1016/0735-1097(94)00543-Y · DOI · Paper page
  93. Mann, 2002, Inflammatory mediators and the failing heart: past, present, and the foreseeable future, Circ Res, 91, 988, 10.1161/01.RES.0000043825.01705.1B · DOI · Paper page
  94. Seta, 1996, Basic mechanisms in heart failure: the cytokine hypothesis, J Card Fail, 2, 243, 10.1016/S1071-9164(96)80047-9 · DOI · Paper page
  95. Mann, 1996, The effect of tumor necrosis factor-alpha on cardiac structure and function: a tale of two cytokines, J Card Fail, 2, S165, 10.1016/S1071-9164(96)80073-X · DOI
  96. Kapadia, 1995, Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration, J Clin Invest, 96, 1042, 10.1172/JCI118090 · DOI · Paper page
  97. Comstock, 1998, LPS-induced TNF-alpha release from and apoptosis in rat cardiomyocytes: obligatory role for CD14 in mediating the LPS response, J Mol Cell Cardiol, 30, 2761, 10.1006/jmcc.1998.0851 · DOI
  98. Kumar, 1996, Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum, J Exp Med, 183, 949, 10.1084/jem.183.3.949 · DOI · Paper page
  99. Yokoyama, 1997, Tumor necrosis factor-alpha provokes a hypertrophic growth response in adult cardiac myocytes, Circulation, 95, 1247, 10.1161/01.CIR.95.5.1247 · DOI · Paper page
  100. Torre-Amione, 1995, Expression and functional significance of tumor necrosis factor receptors in human myocardium, Circulation, 92, 1487, 10.1161/01.CIR.92.6.1487 · DOI · Paper page
  101. Torre-Amione, 1996, Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart, Circulation, 93, 704, 10.1161/01.CIR.93.4.704 · DOI · Paper page
  102. Kapadia S, Dibbs Z, Kurrelmeyer K, Kalra D, Seta Y, Wang F, Bozkurt B, Oral H, Sivasubramanian N, Mann DL. The role of cytokines in the failing human heart. Cardiol Clin 1998; 16(4):645-56, viii. · DOI
  103. Satoh, 1999, Tumor necrosis factor-alpha-converting enzyme and tumor necrosis factor-alpha in human dilated cardiomyopathy, Circulation, 99, 3260, 10.1161/01.CIR.99.25.3260 · DOI
  104. Satoh, 2000, Expression of tumor necrosis factor-alpha-converting enzyme and tumor necrosis factor-alpha in human myocarditis, J Am Coll Cardiol, 36, 1288, 10.1016/S0735-1097(00)00827-5 · DOI
  105. Oral, 2003, Myocardial proinflammatory cytokine expression and left ventricular remodeling in patients with chronic mitral regurgitation, Circulation, 107, 831, 10.1161/01.CIR.0000049745.38594.6D · DOI
  106. Deswal, 2001, Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST), Circulation, 103, 2055, 10.1161/01.CIR.103.16.2055 · DOI · Paper page
  107. Vasan, 2003, Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study, Circulation, 107, 1486, 10.1161/01.CIR.0000057810.48709.F6 · DOI · Paper page
  108. Bryant, 1998, Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha, Circulation, 97, 1375, 10.1161/01.CIR.97.14.1375 · DOI · Paper page
  109. Sivasubramanian, 2001, Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor, Circulation, 104, 826, 10.1161/hc3401.093154 · DOI · Paper page
  110. Franco, 1999, Magnetic resonance imaging and invasive evaluation of development of heart failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha, Circulation, 99, 448, 10.1161/01.CIR.99.3.448 · DOI
  111. Bozkurt, 1998, Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats, Circulation, 97, 1382, 10.1161/01.CIR.97.14.1382 · DOI · Paper page
  112. Bradham, 2002, TNF-alpha and myocardial matrix metalloproteinases in heart failure: relationship to LV remodeling, Am J Physiol Heart Circ Physiol, 282, H1288, 10.1152/ajpheart.00526.2001 · DOI
  113. Li, 2000, Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy, Proc Natl Acad Sci U S A, 97, 12746, 10.1073/pnas.97.23.12746 · DOI · Paper page
  114. Krum, 2002, Tumor necrosis factor-alpha blockade as a therapeutic strategy in heart failure (RENEWAL and ATTACH): unsuccessful, to be specific, J Card Fail, 8, 365, 10.1054/jcaf.2002.130237 · DOI

Cited by

See all 214

Metadata

Authors
Fedak, P. W. M., Verma, S., Weisel, R. D., & Li, R.-K.
Venue
Cardiovascular Pathology
Publisher
Elsevier BV
Published
2005-01
Volume
14
Issue
1
Pages
1-11
ISSN
1054-8807 (ISSN-L)
OpenAlex
W2148001793
Cited by
214
References
17
FWCI
11.67
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cardiac remodeling and failure. https://app.cochat.ai/papers/10.1016/j.carpath.2004.12.002
The paper
Fedak, P. W. M., Verma, S., Weisel, R. D., & Li, R.-K. (2005). Cardiac remodeling and failure. Cardiovascular Pathology. https://doi.org/10.1016/j.carpath.2004.12.002

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.